Sponsor pipeline

IRulya Therapeutics Inc. clinical trial pipeline

Get alerts when IRulya Therapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Primary completion pushed from Jul 16, 2027 to Mar 2028

    Also in this update: Trial sites expanded: 3 → 32 locations; Study completion pushed from Aug 30, 2028 to Feb 2029; and 1 more change in the last 30 days

    IRulya Therapeutics Inc.Phase 2 NCT05798923 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1

Disease areas by active trials

Hypertension (1)

Get alerts when IRulya Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free